New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
January 16, 2014
07:17 EDTBCR, CFN, COV, MASICovidien looking to make acquisitions, NY Times says
Medical device maker Covidien plans to use a portion of its free cash flow for strategic acquisitions in the near-term, the company's CEO said, The New York Times reported yesterday.. Reference Link
News For COV;BCR;MASI;CFN From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
December 17, 2014
05:48 EDTCFNBecton Dickinson named 2015 large cap top pick at Piper Jaffray
Piper Jaffray raised its price target for Becton Dickinson (BDX) shares to $160 from $141 and called the stock its 2015 large cap top pick. Piper expects upside to management's CareFusion (CFN) merger earnings accretion guidance and sees potential gross margin benefit from falling oil prices. The firm keeps an Overweight rating on the stock. Shares of the medical technology company closed yesterday down $1.71 to $134.04.
December 8, 2014
08:31 EDTCFNBecton Dickinson and CareFusion sets date for special meeting in proposed merger
Becton, Dickinson (BDX) and CareFusion (CFN) announced that CareFusion expects to hold a special meeting on January 21, 2015 for CareFusion stockholders to consider and vote upon the proposed merger of CareFusion and BD. As previously announced on October 5, 2014, BD and CareFusion entered into a definitive agreement pursuant to which BD would acquire CareFusion in a stock and cash transaction. CareFusion stockholder approval is a condition to the merger. In addition to CareFusion stockholder approval, the proposed acquisition remains subject to certain other conditions and approvals, including approval of the proposed acquisition by the European Commission under the European Union Merger Regulation. CareFusion has fixed the close of business on December 18, 2014 as the record date for the purpose of determining the stockholders who are entitled to notice of, and to vote at, the special meeting.
08:13 EDTCFNCareFusion announces agreement with Medacist
Subscribe for More Information
December 4, 2014
11:23 EDTCOVAppeals court reverses patent ruling in favor of J&J unit over Covidien
Ethicon Endo-Surgery, a Johnson & Johnson (JNJ) company, appealed a district court judgment regarding certain asserted patent claims of Tyco Healthcare. The appeals court affirmed-in-part, reversed-in-part, and vacated-in-part the prior judgment, because the lower courtís 102(g) findings were correct, but its 103 determination was improper, "including its decision to exclude the 102(g) prior art from the obviousness analysis," the court stated. In 2007, Tyco Healthcare changed its name to Covidien (COV). Reference Link
08:24 EDTCOVChinese Ministry of Commerce clears Medtronic acquisition of Covidien
Subscribe for More Information

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use